Fraunhofer-Gesellschaft, headquartered in Munich, Germany, is Europe's leading organization for applied research. With over 75 institutes and research units across Germany, each focusing on different fields of science and technology, Fraunhofer drives innovation in sectors such as health, security, communication, energy, and environment. The organization's commitment to applied research fosters collaborations with industry, service sectors, and public administration, translating scientific findings into practical applications and promoting technological advancement globally.
This innovative system from Fraunhofer uses radar to track heart activity wirelessly, offering a comfortable, sensor-free solution for continuous patient health monitoring.
An AI-powered full-body scanner detects melanoma early in six minutes. Fraunhofer researchers ensure reliability and safety using explainable AI technologies.
Fraunhofer IMWS researchers developed a cost-effective method using laser swelling to create microlenses by heating polymers, causing internal pressure that forms tiny, durable lenslets.
Researchers are developing digital patient twins to replicate human biology, allowing virtual medication testing and exploring possibilities, challenges, and potential of the technology.
Spatial light modulators enable high-precision light projection, material processing, and optical signal transmission, with potential applications in 3D holography, imaging, and biomedical fields.
Fraunhofer IPMS micro scanners offer high-resolution imaging for endoscopes, microscopy, and spectroscopy, with stable performance and innovative 2D vector scanners enabling faster, precise medical imaging.
Developed by Fraunhofer ISC's SUSI project, the scalable suspension bioreactor will be used for long-term hiPSC culturing, optimizing temperature, CO2 levels, mixing, and shear forces for reproducibility.
The mobile robotic platform developed by Reutlingen University and Fraunhofer IPA in the experimental OR in Strasbourg enables the autonomous transport of medical material and instruments.
Fraunhofer researchers worked together to devise a method modeled on a cascade where multiple successive stages of synthesis proceed without interruption, through the use of novel catalysts in specially adjusted flow-through reactors.